Peptide therapy has moved from niche biohacking circles into mainstream medicine, and the regulatory landscape around it is actively evolving. In Peptide Therapy: Where Do We Go From Here?, providers and patients get a clear-eyed look at what responsible, evidence-based peptide therapy looks like today, and where the field is headed next.

Moderated by Christina Farr (CEO, Second Opinion; GP, Scrub Capital), the panel brings together three perspectives on a fast-moving space: Shaun Noorian, Founder & CEO of Empower Pharmacy, on the pharmacy and access side of peptide therapy; Dr. Rekha Kumar, Senior Medical Advisor at Found, on peptides in weight management and metabolic care; and Dr. Alex Tatem, Corporate Director of Men's Health at U.S. Urology, on their role in men's health and urological care.

Topics covered:

• The current state of peptide therapy and where the science is heading
• How peptides are being used in weight management and metabolic care
• The role of peptides in men's health and urological care
• Navigating safety, sourcing, and quality in a growing market
• What patients should know before starting peptide therapy
• Where regulation, access, and innovation are likely to intersect next